Product type number as specified by the Swiss Structured Products Association (SSPA): 1300
Please consult the termsheet and the accompanying issue prospectus for information on the exact product functionality, product details and risks.
Scenario 1 | Scenario 2 | Scenario 3 | |
---|---|---|---|
Description | Rising underlying | Stagnating underlying | Falling underlying |
Underlying value | 20% share A 20% share B 20% share C 20% D 20% share E |
20% share A 20% share B 20% share C 20% share D 20% share E |
20% share A 20% share B 20% share C 20% share D 20% share E |
Term | 5 years | 5 years | 5 years |
Issue price | CHF 100 | CHF 100 | CHF 100 |
Capital employed | CHF 10'000 (100 Zertifikate) | CHF 10'000 (100 Zertifikate) | CHF 10'000 (100 Zertifikate) |
Basket at initial fixing | CHF 100 | CHF 100 | CHF 100 |
Basket at maturity | CHF 120 | CHF 100 | CHF 80 |
Performance basket | 20% | 0% | -20% |
Scenario 1 | Scenario 2 | Scenario 3 | |
---|---|---|---|
Calculation | 100 Zertifikate * 120 | 100 Zertifikate * 100 | 100 Zertifikate * 80 |
Redemption | CHF 12'000 | CHF 10'000 | CHF 8'000 |
Profit / Loss | 20% | 0% | -20% |
ZKB Reverse Convertible auf Unitedhealth Group Inc 142529913 / CH1425299133 |
ZKB Reverse Convertible on worst of Bank of America Corp/Delta Air Lines Inc (DE)/Unitedhealth Group... 142530984 / CH1425309841 |
ZKB Reverse Convertible auf Unitedhealth Group Inc 142531775 / CH1425317752 |
ZKB Reverse Convertible auf Unitedhealth Group Inc 142531925 / CH1425319253 |
ZKB Callable Reverse Convertible on worst of Bristol-Myers Squibb Co/Unitedhealth Group Inc/Pfizer I... 132910637 / CH1329106376 |